Fragile X Syndrome Testing and the Limitations Associated with Current Maternal Cell Contamination Testing Strategies
Philippa A. Dryland, Annet Damhuis, Douglas I. Rosendale, Kimberley Hughes, Elaine Doherty & Donald R. Love · Journal of Advances in Medicine and Medical Research · 2016
Aims: To assess the level of maternal cell contamination (MCC) that can be detected in the molecular determination of triplet repeat expansions in the FMR1 gene. Place and Duration of Study: Department of Diagnostic Genetics, LabPLUS, Auckland City Hospital, Auckland, New Zealand...
Open access
Research Article
10.9734/BJMMR/2016/28769